We are live on
!
Find out more
B
Bellecapital Portfolio holdings
AUM
$554M
1-Year Est. Return
29.39%
This Fund
S&P 500
This Quarter
Est. Return
+8.11%
1 Year Est. Return
+29.39%
3 Year Est. Return
+99.7%
5 Year Est. Return
+120.39%
10 Year Est. Return
+406.87%
AUM
$413M
AUM Growth
+$11.4M
(+2.8%)
Cap. Flow
-$24.5M
Cap. Flow
% of AUM
-5.92%
Top 10 Holdings %
Top 10 Hldgs %
36.22%
Holding
202
New
10
Increased
37
Reduced
56
Closed
42
Top Buys
| 1 |
Arista Networks
ANET
|
+$8.62M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$6.31M |
| 3 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$1.48M |
| 4 |
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
|
+$1.33M |
| 5 |
3M
MMM
|
+$834K |
Top Sells
| 1 |
Charles River Laboratories
CRL
|
+$4.89M |
| 2 |
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
|
+$4.23M |
| 3 |
Amazon
AMZN
|
+$2.62M |
| 4 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$2.43M |
| 5 |
Spotify
SPOT
|
+$2.41M |
Sector Composition
| 1 | Technology | 28.01% |
| 2 | Consumer Staples | 12.57% |
| 3 | Healthcare | 11.71% |
| 4 | Consumer Discretionary | 8.52% |
| 5 | Communication Services | 8.4% |
Similar funds
LFS
TC
SIM
AWA
FFA
CCA
HWM
TPA
Bellecapital's Q2 2023 Portfolio in Review
As of Q2 2023, Bellecapital held 202 positions worth $413M, up 2.8% from $402M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Bellecapital withdrew a net $24.5M in Q2 2023, closing 42 positions and reducing 56 holdings. Its most notable exit was Charles River Laboratories, an estimated $4.89M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 23% a quarter earlier, followed by Consumer Staples and Healthcare.
Against the trend, Bellecapital opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $6.35M.
- Bellecapital's largest Q2 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 84,622 shares worth $6.35M.
- Bellecapital added most to Arista Networks in Q2 2023, an estimated $8.62M increase.
- Bellecapital's biggest Q2 2023 reduction was PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund, cutting an estimated $4.23M.
- Bellecapital fully exited Charles River Laboratories in Q2 2023, selling an estimated $4.89M.
- Bellecapital's ten largest holdings make up 36% of its $413M portfolio in Q2 2023.
- Bellecapital opened 10 new positions and closed 42 in Q2 2023.
- Bellecapital's portfolio value rose 2.8% quarter-over-quarter to $413M.
Based on Bellecapital's 13F filing for Q2 2023, filed 7 Jul 2023.